CareCloud (CCLD) Stock Overview
A healthcare information technology company, provides technology-enabled business solutions, Software-as-a-Service offerings, and related business services to healthcare providers and hospitals primarily in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for CCLD from our risk checks.
CCLD Community Fair Values
Create NarrativeSee what 32 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
CareCloud, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$2.97 |
| 52 Week High | US$4.01 |
| 52 Week Low | US$1.71 |
| Beta | 1.83 |
| 1 Month Change | -15.63% |
| 3 Month Change | 7.22% |
| 1 Year Change | 62.30% |
| 3 Year Change | -3.57% |
| 5 Year Change | -61.18% |
| Change since IPO | -30.61% |
Recent News & Updates
CCLD: Capital Discipline And AI Adoption Will Drive Future Repricing Confidence
Analysts have adjusted their price target on CareCloud to $6.31, citing concerns that acquisitive activity and plans for an aircraft purchase may be obscuring underlying revenue softness and creating questions around capital allocation discipline. Analyst Commentary Analyst commentary around CareCloud centers on how acquisitions and capital allocation choices, including the planned aircraft purchase, may influence the company’s ability to deliver consistent execution and support the current valuation.
CCLD: Cost Controls And AI Automation Will Offset Acquisition And Aircraft Spending
Analysts have reaffirmed their $3.25 price target on CareCloud, citing recent results as reasonable. However, they expressed concern that acquisitions, including a planned aircraft purchase for client visits, may be obscuring the company’s underlying revenue trends.
CCLD: Clearer Organic Revenue Disclosure Will Support Future Upside Potential
Narrative Update on CareCloud Analysts have reduced their CareCloud price target to $3.25, reflecting concerns that recent acquisitions and the planned aircraft purchase may be masking underlying revenue declines rather than supporting a stronger long term outlook. Analyst Commentary Recent commentary points to a cautious stance on CareCloud, with the current US$3.25 price target described as reflecting concern that acquisitions and the planned aircraft purchase may be masking underlying revenue pressure rather than supporting a clearer long term growth story.Recent updates
CCLD: Capital Discipline And AI Adoption Will Drive Future Repricing Confidence
Analysts have adjusted their price target on CareCloud to $6.31, citing concerns that acquisitive activity and plans for an aircraft purchase may be obscuring underlying revenue softness and creating questions around capital allocation discipline. Analyst Commentary Analyst commentary around CareCloud centers on how acquisitions and capital allocation choices, including the planned aircraft purchase, may influence the company’s ability to deliver consistent execution and support the current valuation.CCLD: Cost Controls And AI Automation Will Offset Acquisition And Aircraft Spending
Analysts have reaffirmed their $3.25 price target on CareCloud, citing recent results as reasonable. However, they expressed concern that acquisitions, including a planned aircraft purchase for client visits, may be obscuring the company’s underlying revenue trends.CCLD: Clearer Organic Revenue Disclosure Will Support Future Upside Potential
Narrative Update on CareCloud Analysts have reduced their CareCloud price target to $3.25, reflecting concerns that recent acquisitions and the planned aircraft purchase may be masking underlying revenue declines rather than supporting a stronger long term outlook. Analyst Commentary Recent commentary points to a cautious stance on CareCloud, with the current US$3.25 price target described as reflecting concern that acquisitions and the planned aircraft purchase may be masking underlying revenue pressure rather than supporting a clearer long term growth story.CCLD: Higher Margins And New Contracts Will Support Future Upside
Analysts have trimmed CareCloud's price target to $3.25. This reflects concerns that acquisitive activity, including the planned aircraft purchase, is obscuring underlying revenue softness, even as profit margin assumptions improve and future P/E expectations reset lower.CCLD: Supply Chain And Urgent Care Expansion Will Support Future Upside
Analysts have adjusted their CareCloud price target to reflect updated assumptions on discount rate, revenue growth, profit margin, and future P/E. This has led to a revised view of the potential upside for the shares.CCLD: Cost Controls And AI Automation Will Drive Future Repricing Potential
Analysts have updated their view on CareCloud with a revised $3.25 price target, citing refreshed assumptions for revenue growth, profit margins, discount rate and future P/E, while also pointing to recent Street research, including new coverage with an $8 target, as context for the valuation range. Analyst Commentary The refreshed $3.25 target sits well below the new $8 initiation level referenced in Street research, which highlights how split opinions are around CareCloud’s execution and valuation.Take Care Before Diving Into The Deep End On CareCloud, Inc. (NASDAQ:CCLD)
Feb 04
CCLD: Cost Discipline And AI Rollout Will Support Future Rerating Potential
Analysts have nudged their price target for CareCloud higher, with some recent research pointing to a range up to US$8. This reflects revised assumptions for cost controls, a flatter near term revenue and EBITDA outlook, and a higher future P/E multiple in their models.CareCloud: Undervalued AI Play In Healthcare IT
Jan 29CCLD: Cost Controls And AI Automation Will Support Future Repricing
Analysts have adjusted their price target on CareCloud to $3.25 based on updated views of revenue growth, profit margins, cost controls, and long-term P/E assumptions following recent research, including new coverage with an $8 target and revised estimates after the latest Q3 report. Analyst Commentary Recent research on CareCloud reflects a mix of optimism and restraint, with one firm starting coverage at a higher price target and others resetting expectations closer to current fundamentals.CCLD: Cost Controls And New AI Offering Will Support Future Upside
Narrative Update on CareCloud Analysts have lifted their price target on CareCloud to $3.25 from $2.25, citing updated forecasts for revenue growth, a different margin profile, a higher assumed future P/E multiple, and recent Street research that includes new coverage and refreshed estimates following the Q3 report. Analyst Commentary Recent Street research on CareCloud offers a mixed picture, with some upbeat coverage alongside more cautious views.CCLD: Cost Controls And EBITDA Durability Will Drive Shares Higher
Analysts have raised their price target on CareCloud to $8.00 from prior levels near $3.25, citing new Buy-rated coverage and expectations that tighter cost controls will support near term EBITDA even as revenue growth moderates. Analyst Commentary Bullish analysts point to recent price target increases as evidence that the market may be underestimating CareCloud's ability to sustain profitability while navigating slower top line growth.CCLD: Improved Cost Controls Will Sustain Near-Term Profitability Momentum
CareCloud's analyst price target has increased from $5.75 to $6.31, reflecting a slightly improved near-term outlook as analysts cite cost controls and recent Buy ratings, even as revenue and margin expectations moderate. Analyst Commentary Recent analyst notes on CareCloud highlight both positive and cautious perspectives regarding the company’s outlook and valuation.CCLD: Improved Cost Controls Will Drive Higher Near-Term Profitability
CareCloud's analyst price target has been raised by $1.00 to $3.25, as analysts point to improved cost controls and a stable near-term earnings outlook following recent updates to estimates. Analyst Commentary Following recent updates, analysts have offered perspectives highlighting both the positive developments and ongoing concerns for CareCloud.There's No Escaping CareCloud, Inc.'s (NASDAQ:CCLD) Muted Revenues Despite A 30% Share Price Rise
Aug 26There's No Escaping CareCloud, Inc.'s (NASDAQ:CCLD) Muted Revenues Despite A 33% Share Price Rise
May 01
CirrusAI, Series Conversion And Acquisition Reentry Will Unlock New Opportunities
AI-driven solutions and innovations, including CirrusAI, position CareCloud for enhanced revenue growth and new market opportunities.Analysts Have Been Trimming Their CareCloud, Inc. (NASDAQ:CCLD) Price Target After Its Latest Report
Mar 16Not Many Are Piling Into CareCloud, Inc. (NASDAQ:CCLD) Stock Yet As It Plummets 65%
Mar 13CareCloud (NASDAQ:CCLD) Is Looking To Continue Growing Its Returns On Capital
Feb 19The Market Doesn't Like What It Sees From CareCloud, Inc.'s (NASDAQ:CCLD) Revenues Yet As Shares Tumble 25%
Jan 18CareCloud, Inc. (NASDAQ:CCLD) Shares Fly 34% But Investors Aren't Buying For Growth
Nov 13We Think CareCloud (NASDAQ:CCLD) Has A Fair Chunk Of Debt
Oct 07CareCloud, Inc. (NASDAQ:CCLD) Shares Fly 25% But Investors Aren't Buying For Growth
Aug 31CareCloud, Inc. (NASDAQ:CCLD) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough
Jul 13We Think CareCloud (NASDAQ:CCLD) Has A Fair Chunk Of Debt
Jun 27CareCloud, Inc. (NASDAQ:CCLD) Held Back By Insufficient Growth Even After Shares Climb 158%
May 22CareCloud, Inc. (NASDAQ:CCLD) Shares Could Be 42% Below Their Intrinsic Value Estimate
Mar 22The Market Doesn't Like What It Sees From CareCloud, Inc.'s (NASDAQ:CCLD) Revenues Yet As Shares Tumble 27%
Mar 22Little Excitement Around CareCloud, Inc.'s (NASDAQ:CCLD) Revenues As Shares Take 25% Pounding
Feb 02Is CareCloud (NASDAQ:CCLD) Using Too Much Debt?
Jan 30CareCloud, Inc.'s (NASDAQ:CCLD) 31% Dip In Price Shows Sentiment Is Matching Revenues
Dec 19Is CareCloud (NASDAQ:CCLD) A Risky Investment?
Sep 28Things Look Grim For CareCloud, Inc. (NASDAQ:CCLD) After Today's Downgrade
Aug 05There's No Escaping CareCloud, Inc.'s (NASDAQ:CCLD) Muted Revenues
Aug 01CareCloud, Inc. (NASDAQ:CCLD) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
May 06There's Been No Shortage Of Growth Recently For CareCloud's (NASDAQ:CCLD) Returns On Capital
Mar 05Shareholder Returns
| CCLD | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | -7.2% | -1.8% | -0.2% |
| 1Y | 62.3% | -38.9% | 27.6% |
Return vs Industry: CCLD exceeded the US Healthcare Services industry which returned -38.2% over the past year.
Return vs Market: CCLD exceeded the US Market which returned 29.1% over the past year.
Price Volatility
| CCLD volatility | |
|---|---|
| CCLD Average Weekly Movement | 10.3% |
| Healthcare Services Industry Average Movement | 10.5% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.3% |
Stable Share Price: CCLD has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: CCLD's weekly volatility (10%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 3,650 | Stephen Snyder | www.carecloud.com |
CareCloud, Inc., a healthcare information technology company, provides technology-enabled business solutions, Software-as-a-Service offerings, and related business services to healthcare providers and hospitals primarily in the United States. It operates through Healthcare IT and Medical Practice Management segments. The company’s proprietary software and business services includes technology-enabled business solutions; cloud-based software; digital health services; healthcare IT professional services and staffing; MAP App; and medical practice management services.
CareCloud, Inc. Fundamentals Summary
| CCLD fundamental statistics | |
|---|---|
| Market cap | US$135.13m |
| Earnings (TTM) | US$3.89m |
| Revenue (TTM) | US$120.50m |
32.4x
P/E Ratio1.0x
P/S RatioIs CCLD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CCLD income statement (TTM) | |
|---|---|
| Revenue | US$120.50m |
| Cost of Revenue | US$64.46m |
| Gross Profit | US$56.04m |
| Other Expenses | US$52.15m |
| Earnings | US$3.89m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
May 07, 2026
| Earnings per share (EPS) | 0.092 |
| Gross Margin | 46.51% |
| Net Profit Margin | 3.23% |
| Debt/Equity Ratio | 2.0% |
How did CCLD perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/04/29 10:26 |
| End of Day Share Price | 2026/04/29 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
CareCloud, Inc. is covered by 8 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Marc Wiesenberger | B. Riley Securities, Inc. |
| Keay Nakae | Chardan Capital Markets, LLC |
| Eugene Mannheimer | Colliers Securities |